OC50.FFrankfurt
Cochlear Limited
€30.00
ListedFeb 3, 2021
SectorHealthcare
IndustryMedical Devices
CountryAustralia
Employees5500
StateNSW| CitySydney| Address1 University Avenue| Phone61 2 9428 6555
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products. It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories. The company was founded in 1981 and is headquartered in Sydney, Australia.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
18.5
?
Div. Rate
€1.24
?
Div. Yield
4.14%
?
Payout Ratio
80.78%
?
Max Consec. Div. Years
5 years
?
Longest Consec. Div.
4 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.15
?
Div. Growth Rate
100.00%
?
Score
96

Dividend History

Historical dividend payments by ex-dividend date.

Mar 20, 2026
€ 0.6519
Sep 19, 2025
€ 0.5933
Mar 21, 2025
€ 0.5821
Sep 18, 2024
€ 0.6039
Mar 21, 2024
€ 0.5552
Sep 15, 2023
€ 0.4807
Mar 20, 2023
€ 0.4493
Sep 21, 2022
€ 0.3893
Mar 25, 2022
€ 0.4940
Sep 22, 2021
€ 0.4436
Mar 24, 2021
€ 0.3831

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!